Direct thrombin inhibitor melagatran followed by oral ximelagatran in comparison with enoxaparin for prevention of venous thromboembolism after total hip or knee replacement. The METHRO III study - Eriksson, BI; Agnelli, G; Cohen, AT; METHRO III Study Group (Thromb Haemost, 2003)
et al. on behalf of the